Lammert F, Wang D Q, Paigen B, Carey M C
Department of Medicine, Harvard Medical School, Gastroenterology Division, Brigham and Women's Hospital, and Harvard Digestive Diseases Center, Boston, MA 02115, USA.
J Lipid Res. 1999 Nov;40(11):2080-90.
There is no consensus whether hepatic lipid regulatory enzymes play primary or secondary roles in cholesterol cholelithiasis. We have used inbred mice with Lith genes that determine cholesterol gallstone susceptibility to evaluate the question. We studied activities of regulatory enzymes in cholesterol biosynthesis (HMG-CoA reductase), cholesterol esterification (acyl-CoA:cholesterol acyltransferase) and the "neutral" (cholesterol 7alpha-hydroxylase) and "acidic" (sterol 27-hydroxylase) pathways of bile salt synthesis in strains C57L/J and SWR/J as well as recombinant inbred (AKXL-29) mice, all of which have susceptible Lith alleles, and compared them to AKR/J mice with resistant Lith alleles. We determined hepatic enzyme activities of male mice before and at frequent intervals during feeding a lithogenic diet (15% dairy fat, 1% cholesterol, 0.5% cholic acid) for 12 weeks. Basal activities on chow show significant genetic variations for HMG-CoA reductase, sterol 27-hydroxylase, and acyl-CoA: cholesterol acyltranferase, but not for cholesterol 7alpha-hydroxylase. In response to the lithogenic diet, activities of the regulatory enzymes in the two bile salt synthetic pathways are coordinately down-regulated and correlate inversely with prevalence rates of cholesterol crystals and gallstones. Compared with gallstone-resistant mice, significantly higher HMG-CoA reductase activities together with lower activities of both bile salt synthetic enzymes are hallmarks of the enzymatic phenotype in mice with susceptible Lith alleles. The most parsimonious explanation for the multiple enzymatic alterations is that the primary Lith phenotype induces secondary events to increase availability of cholesterol to supply the sterol to the hepatocyte canalicular membrane for hypersecretion into bile.
关于肝脏脂质调节酶在胆固醇性胆结石形成中起主要还是次要作用,目前尚无定论。我们利用具有决定胆固醇胆结石易感性的Lith基因的近交系小鼠来评估这个问题。我们研究了胆固醇生物合成(HMG-CoA还原酶)、胆固醇酯化(酰基辅酶A:胆固醇酰基转移酶)以及胆汁酸合成的“中性”(胆固醇7α-羟化酶)和“酸性”(甾醇27-羟化酶)途径中调节酶的活性,研究对象包括C57L/J和SWR/J品系以及重组近交(AKXL-29)小鼠,所有这些小鼠都具有易感性Lith等位基因,并将它们与具有抗性Lith等位基因的AKR/J小鼠进行比较。我们测定了雄性小鼠在喂食致石性饮食(15%乳脂肪、1%胆固醇、0.5%胆酸)12周之前及期间频繁时间点的肝脏酶活性。普通饲料喂养时的基础活性显示,HMG-CoA还原酶、甾醇27-羟化酶和酰基辅酶A:胆固醇酰基转移酶存在显著的基因变异,但胆固醇7α-羟化酶没有。对致石性饮食的反应中,两条胆汁酸合成途径中调节酶的活性协同下调,且与胆固醇晶体和胆结石的发生率呈负相关。与抗胆结石小鼠相比,具有易感性Lith等位基因的小鼠中,HMG-CoA还原酶活性显著更高,同时两种胆汁酸合成酶的活性更低,这是酶表型的特征。对多种酶改变最简洁的解释是,原发性Lith表型引发继发性事件,以增加胆固醇的可利用性,从而为肝细胞胆小管膜提供甾醇,使其过度分泌到胆汁中。